- Home
- PFX vs ADAG Comparison
PFX vs ADAG Comparison
Compare PFX & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFX
- ADAG
- Stock Information
- Founded
- PFX 2010
- ADAG 2011
- Country
- PFX United States
- ADAG China
- Employees
- PFX N/A
- ADAG N/A
- Industry
- PFX Finance: Consumer Services
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- PFX Finance
- ADAG Health Care
- Exchange
- PFX Nasdaq
- ADAG Nasdaq
- Market Cap
- PFX 96.4M
- ADAG 110.8M
- IPO Year
- PFX N/A
- ADAG 2021
- Fundamental
- Price
- PFX $43.58
- ADAG $1.78
- Analyst Decision
- PFX
- ADAG Strong Buy
- Analyst Count
- PFX 0
- ADAG 3
- Target Price
- PFX N/A
- ADAG $7.67
- AVG Volume (30 Days)
- PFX 2.2K
- ADAG 77.4K
- Earning Date
- PFX 12-16-2025
- ADAG 08-12-2025
- Dividend Yield
- PFX 3.28%
- ADAG N/A
- EPS Growth
- PFX N/A
- ADAG N/A
- EPS
- PFX 3.06
- ADAG N/A
- Revenue
- PFX $23,958,590.00
- ADAG $103,204.00
- Revenue This Year
- PFX $10.24
- ADAG $7,411.34
- Revenue Next Year
- PFX N/A
- ADAG $28.29
- P/E Ratio
- PFX $14.25
- ADAG N/A
- Revenue Growth
- PFX 7.47
- ADAG N/A
- 52 Week Low
- PFX $41.80
- ADAG $1.33
- 52 Week High
- PFX $57.40
- ADAG $3.16
- Technical
- Relative Strength Index (RSI)
- PFX 33.40
- ADAG 43.32
- Support Level
- PFX $42.39
- ADAG $1.75
- Resistance Level
- PFX $45.38
- ADAG $1.95
- Average True Range (ATR)
- PFX 0.84
- ADAG 0.12
- MACD
- PFX -0.26
- ADAG 0.01
- Stochastic Oscillator
- PFX 21.41
- ADAG 26.09
About PFX PhenixFIN Corporation
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.